| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOCEL.2011.02.002 |
| P8608 | Fatcat ID | release_gty3lkmxfrcn5mxcf2tqd5pmjy |
| P698 | PubMed publication ID | 21315177 |
| P2093 | author name string | David Ostrov | |
| Mini Sajan | |||
| Robert Farese | |||
| Rekha Patel | |||
| Mildred Acevedo-Duncan | |||
| Shraddha Desai | |||
| Prajit Pillai | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 784-794 | |
| P577 | publication date | 2011-02-16 | |
| P1433 | published in | International Journal of Biochemistry & Cell Biology | Q6051320 |
| P1476 | title | A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma | |
| P478 | volume | 43 |
| Q58173395 | A Cancer-Associated Mutation in Atypical Protein Kinase C Occurs in a Substrate-Specific Recruitment Motif |
| Q35652151 | A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins. |
| Q54977138 | A Novel Atypical PKC-Iota Inhibitor, Echinochrome A, Enhances Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells. |
| Q91558288 | A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells |
| Q27684030 | Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes |
| Q47651314 | Atypical PKC, PKCλ/ι, activates β-secretase and increases Aβ1-40/42 and phospho-tau in mouse brain and isolated neuronal cells, and may link hyperinsulinemia and other aPKC activators to development of pathological and memory abnormalities in Alzhei |
| Q38162656 | Atypical protein kinase Cι as a human oncogene and therapeutic target |
| Q39119454 | Biochemistry and neuroscience: the twain need to meet |
| Q38064457 | Cell cycle-related kinase in carcinogenesis |
| Q36908820 | Compensation for PKMζ in long-term potentiation and spatial long-term memory in mutant mice. |
| Q37205686 | Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι |
| Q90216826 | Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway |
| Q26851833 | Emerging role of cell polarity proteins in breast cancer progression and metastasis |
| Q33711530 | Expression of PKC iota affects neuronal differentiation of PC12 cells at least partly independent of kinase function. |
| Q92490693 | Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues |
| Q58696958 | Inhibition of atypical protein kinase C‑ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade |
| Q35722786 | Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2 |
| Q36526711 | Insulin signalling in hepatocytes of humans with type 2 diabetes: excessive production and activity of protein kinase C-ι (PKC-ι) and dependent processes and reversal by PKC-ι inhibitors |
| Q47123431 | Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic target |
| Q90182658 | Isoform Specificity of PKMs during Long-Term Facilitation in Aplysia Is Mediated through Stabilization by KIBRA |
| Q34313113 | Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction |
| Q54978684 | Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors. |
| Q60305001 | Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic |
| Q21131217 | Protein kinase C signaling and cell cycle regulation |
| Q39453904 | Regulation of Cdk7 activity through a phosphatidylinositol (3)-kinase/PKC-ι-mediated signaling cascade in glioblastoma |
| Q37537542 | Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids. |
| Q37673912 | Targeting oncogenic protein kinase Cι for treatment of mutant KRAS LADC. |
| Q38981224 | The interruption of PKC-ι signaling and TRAIL combination therapy against glioblastoma cells |
| Q42378305 | Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis. |
| Q91743620 | aPKC in neuronal differentiation, maturation and function |
Search more.